Aduro Biotech CVR
13F holders, Q2 2024 (June 30)2holders
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Aduro Biotech CVR in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Bessemer Group Inc. ($0) and Rhumbline Advisers ($0).
- Company
- Aduro Biotech CVR
- CUSIP
- 007CVR012
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 146,063 shares bought and 185,345 shares sold, net −39,282 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Bessemer Group Inc. | 0.00% | New | 146,063 | $0 |
| Rhumbline Advisers | 0.00% | Reduce -0.5% | 14,637 | $0 |
"% of holder's portfolio" is ADURO BIOTECH CVR's weight in each manager's 13F, not the share of Aduro Biotech CVR the manager owns.